Product Information
Molecular Weight 410.5
Purity 99% (TLC)
Recommended Dilutions Activates adenylate cyclase by directly interacting with the catalytic subunit of the enzyme EC50=2-10 μM. Cell permeable and active in vivo. Most cell culture studies employ a working concentration of 5 or 10 μM. Do not make stock solutions in ethanol. Ethanol inhibits forskolin activation of adenylate cyclase. 1,9-Dideoxyforskolin may be used as a negative control.
Storage/Stability Store solutions at -20°C for up to 1 year.
References1) Merck Index 13, 2500
2) Review K.B. Seamon Annu. Rep. Med. Chem. 1984 19 293
3) K.B. Seamon and J.W. Daly Adv. Cyclic Nucl. Res. 1986 20 1
4) A. Laurenza et al. Trends Pharmacol. Sci. 1989 10 442
5) N.J. De Souza et al. Med. Res. Rev. 1983 3 201
6) R.D. Huang J. Cyclic Nucl. Res. 1982 8 385
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.